Media Inquiries

For media inquiries please contact:

[email protected]

2025

Inside Cantor’s SPAC and Crypto Leadership

The closing of Twenty One Capital (NYSE: $XXI)’s combination with $CEP marks a watershed moment for Bitcoin DATs. As Chairman Brandon Lutnick explains, Cantor Fitzgerald’s SPAC and Crypto leadership played a key role in bringing the deal to life.

11 December, 2025
Beau's IPO market update

Investors have been eagerly awaiting a stronger IPO market for years, and Beau Bohm, Cantor’s Global Co-Head of Equity Capital Markets, is noticing signs of a shift finally materializing. Hear about what he’s observing, particularly in the tech, fintech, and industrials sectors. Disclaimer – Cantor | Cantor

29 October, 2025
Understanding oncology radiopharmaceuticals

Radiopharmaceuticals are rapidly transforming oncology by offering unprecedented potency in targeting tumor cells. Senior Biotech Analyst Li Watsek explains the science and logistics behind this highly effective radiation therapy. Disclaimer – Cantor | Cantor

22 October, 2025
The state of the IPO market

Cantor’s Beau Bohm lays out some of the trends that signify to him the IPO market is finding its rhythm again. Disclaimer – Cantor | Cantor

26 August, 2025
Themes in space exploration

Commercial space exploration is poised to advance in light of the latest presidential executive order aimed at increasing launch missions and industry competition. Senior Research Analyst Andres Sheppard examines how policy developments and technological advances are helping exploration reach new heights. Disclaimer – Cantor | Cantor

20 August, 2025
Staying ahead of the curve

Staying ahead of the curve is crucial for identifying biotech companies with growth potential. Senior Biotech Analyst Steve Seedhouse monitors novel approaches, such as RNA editing, to evaluate their advancements in treatment and positive impacts on health outcomes. Disclaimer – Cantor | Cantor

4 August, 2025
What it means to be an advisor

Cantor serves as a trusted strategic advisor for many early-to-mid-stage growth companies. Mark Baillie, MD, Enterprise Software Investment Banking, shares some strategies and opportunities that emerging business owners may not know how to effectively leverage on their own. Disclaimer – Cantor | Cantor

4 June, 2025
On the cusp of autonomy

Self-driving technology is putting the pedal to the metal—turns out, the future might not need a driver’s license. Senior Equity Research Analyst Andres Sheppard explains how advancements in self-driving vehicles—both for consumers and commercial—are meeting market needs and how evolving regulations could help move the technology forward. Disclaimer – Cantor | Cantor

19 May, 2025
Fueling tech's energy demand

Technological advances are key to solving for both increasing energy demand and the need for efficiency, says Cole Bader, Cantor’s Global Head of Technology Investment Banking. Disclaimer – Cantor | Cantor

15 May, 2025
IT infrastructure spending

Mark Baillie, a managing director in Cantor’s Technology Investment Banking Group, works with enterprise software clients to grow through investment or M&A. In this edition of Cantor Calls, Mark explains how he advises clients to differentiate themselves in the modern technology vendor landscape, while drawing on familiar technology challenges existing for decades.  Disclaimer – Cantor | […]

13 May, 2025
M&A trends with Cole Bader

Investor activity is adapting to evolving market conditions, with Cole Bader, Global Head of Technology Investment Banking, offering insights on how this dynamic may create opportunities for certain technology companies in the coming months. Disclaimer – Cantor | Cantor

7 May, 2025
Semiconductors in focus: The impact of AI & geopolitics

The semiconductor industry is poised for an uptick. While AI and memory demand are high, the rest of the industry has been in a downturn— a trend Cantor’s CJ Muse anticipates will reverse. For Important Disclosures, see: Disclaimer – Cantor | Cantor

13 March, 2025